Sam Brusco, Associate Editor07.29.23
Happy weekend, MPO readers!
Dominating the headlines this week was the U.S. Food and Drug Administration (FDA) clearance of Acurable’s AccuPebble device for obstructive sleep apnea. Following closely behind was MPO’s annual Top 30 Medical Device Companies report, with a new leader at the top. Taking the bronze was Medtronic’s release of its PULSED AF study evaluating its PulseSelect pulsed field ablation system for atrial arrythmia.
Dominating the headlines this week was the U.S. Food and Drug Administration (FDA) clearance of Acurable’s AccuPebble device for obstructive sleep apnea. Following closely behind was MPO’s annual Top 30 Medical Device Companies report, with a new leader at the top. Taking the bronze was Medtronic’s release of its PULSED AF study evaluating its PulseSelect pulsed field ablation system for atrial arrythmia.